Sign In
Buy HSIC
$75.74
-0.300 (-0.395%)
At Close: Jun 03, 2026
Henry Schein Commits to Advance ESG Stewardship
11:09am, Wednesday, 12'th May 2021
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today a series of
Henry Schein One Announces Enhancement of Its axiUm Dental Software by Integrating Dental and Medical Patient Records
08:04am, Tuesday, 11'th May 2021
AMERICAN FORK, Utah--(BUSINESS WIRE)--Henry Schein One Announces Enhancement of its AxiUm Dental Software by Integrating Dental and Medical Patient Records
Henry Schein (HSIC) Hits New 52-Week High: What's Driving It?
10:31am, Monday, 10'th May 2021
Henry Schein (HSIC) is optimistic about maintaining robust sales of PPE and COVID-19-related products.
Henry Schein (HSIC) Soars 7.9%: Is Further Upside Left in the Stock?
07:54am, Wednesday, 05'th May 2021
Henry Schein (HSIC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down th
Henry Schein, Inc. (HSIC) CEO Stanley Bergman on Q1 2021 Results - Earnings Call Transcript
04:47pm, Tuesday, 04'th May 2021
Henry Schein, Inc. (HSIC) CEO Stanley Bergman on Q1 2021 Results - Earnings Call Transcript
Henry Schein Stock Is Trading Higher On Beating On Q1 Earnings, Raised EPS Guidance
12:23pm, Tuesday, 04'th May 2021
Henry Schein Inc (NASDAQ: HSIC) raised its 2021 guidance after reporting first-quarter earnings, which topped the consensus. It posted an adjusted EPS of $1.24 ahead of the consensus of $0.85.
Henry Schein (HSIC) Q1 Earnings Top Estimates, '21 EPS View Up
12:02pm, Tuesday, 04'th May 2021
Henry Schein (HSIC) sees robust segmental performance in Q1 boosted by strong rebound in sales, and solid demand for PPE and COVID-19-related products.
Henry Schein (HSIC) Q1 Earnings and Revenues Surpass Estimates
09:02am, Tuesday, 04'th May 2021
Henry Schein (HSIC) delivered earnings and revenue surprises of 49.40% and 3.55%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Recap: Henry Schein Q1 Earnings
07:09am, Tuesday, 04'th May 2021
Shares of Henry Schein (NASDAQ:HSIC) decreased 3.0% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 31.91% over the past year to $1.24, whic
HSIC vs. SAUHF: Which Stock Is the Better Value Option?
06:17pm, Wednesday, 28'th Apr 2021
HSIC vs. SAUHF: Which Stock Is the Better Value Option?
Henry Schein to Present at the Bank of America Securities 2021 Virtual Health Care Conference
08:05am, Tuesday, 27'th Apr 2021
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein to present at the Bank of America Securities 2021 virtual health care conference.
Henry Schein CEO Stanley M. Bergman Submits Letter to Congressional Subcommittee Supporting Expanded COVID Vaccine Distribution
11:00am, Thursday, 22'nd Apr 2021
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein CEO Stanley Bergman submits letter to congressional subcommittee supporting expanded COVID vaccine distribution.
5 MedTech Outperformers With Nearly 40% or More Gain in 2021
09:50am, Friday, 16'th Apr 2021
Here are a few MedTech stocks, Natus Medical (NTUS), Owens & Minor (OMI), ENDRA Life Sciences (NDRA), Penumbra (PEN), Apollo Medical (AMEH), which might be prudent investment choices now.
Henry Schein's (HSIC) New Deal Boosts Ambulatory Surgery Market
11:22am, Wednesday, 31'st Mar 2021
Henry Schein's (HSIC) recent majority ownership in Stradis Healthcare will advance the former's commitment to offer specialty solutions to customers.
Here's Why You Should Retain Henry Schein (HSIC) Stock For Now
03:21pm, Tuesday, 30'th Mar 2021
Investors continue to be optimistic about Henry Schein (HSIC) on robust sales of PPE and COVID-19-related products.
